The ultimate goal of the Laboratory is to translate the most tangible basic neuroscience discoveries into clinical therapies to improve function and impede major complications following SCI and other neurological disorders.
Yang (Ted) D. Teng, Ph.D., M.S., M.D.
Lab Director and Co-Director of Neurotrauma Recovery Research
Neural stem cell transplants slow progression of ALS
Results from a meta-analysis of 11 independent amyotrophic lateral sclerosis (ALS) research studies are giving hope to the ALS community by showing, for the first time, that the fatal disease may be treatable. Researchers say progress in treating ALS, also known as Lou Gehrig’s disease, may be made by targeting new mechanisms revealed by neural stem cell-based studies.
